Abstract
Late life depression is a prevalent disorder that affects elderly population. However, it is frequently sub diagnosed due to great variability in the sample involved, the definition of depression, the methodology used, and the experience of the evaluator.
Different subtypes of geriatric depression exist, each one with its own clinical characteristics. Depressive symptoms often are accompanied by cognitive impairment. Various diagnostic studies must be done to evaluate late life depression, such as depression scales, neuropsychological test, laboratory analyses and Neuroimages. As regards to treatment, antidepressants are always the first line option, especially IRSS due to its effectiveness and low rates of adverse events. Antipsychotics may provide benefit for agitated, psychotic, or resistant MDD in the elderly. Mood stabilizers are useful in bipolar depression such as lamotrigine, lithium and divalproate. This review aims to define the different subtypes of geriatric depression, describe diagnostic methods and revise recent data about pharmacological treatment.
Keywords: Clinical manifestations, diagnosis, late life depression, treatment.
Current Psychopharmacology
Title:Late Life Depression: A Diagnostic and Pharmacological Review
Volume: 3
Author(s): Carol Dillon, Clara Rodriguez and Fernando E. Taragano
Affiliation:
Keywords: Clinical manifestations, diagnosis, late life depression, treatment.
Abstract: Late life depression is a prevalent disorder that affects elderly population. However, it is frequently sub diagnosed due to great variability in the sample involved, the definition of depression, the methodology used, and the experience of the evaluator.
Different subtypes of geriatric depression exist, each one with its own clinical characteristics. Depressive symptoms often are accompanied by cognitive impairment. Various diagnostic studies must be done to evaluate late life depression, such as depression scales, neuropsychological test, laboratory analyses and Neuroimages. As regards to treatment, antidepressants are always the first line option, especially IRSS due to its effectiveness and low rates of adverse events. Antipsychotics may provide benefit for agitated, psychotic, or resistant MDD in the elderly. Mood stabilizers are useful in bipolar depression such as lamotrigine, lithium and divalproate. This review aims to define the different subtypes of geriatric depression, describe diagnostic methods and revise recent data about pharmacological treatment.
Export Options
About this article
Cite this article as:
Dillon Carol, Rodriguez Clara and Taragano E. Fernando, Late Life Depression: A Diagnostic and Pharmacological Review, Current Psychopharmacology 2014; 3 (1) . https://dx.doi.org/10.2174/2211556003666140702185640
DOI https://dx.doi.org/10.2174/2211556003666140702185640 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Vignettes: Integrated Care of Cancer Patients by Oncologists and Cardiologists
Current Cardiology Reviews L-Arginine Transport and Nitric Oxide Production in Kinin Receptor B1-/- Endothelial Cells.
Protein & Peptide Letters Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology Nicotinic Acetylcholine Receptor Agonists: A Potential New Class of Analgesics
Current Topics in Medicinal Chemistry Adipobiology for Novel Therapeutic Approaches in Metabolic Syndrome
Current Vascular Pharmacology The Use of Biomarkers for Assessing HAART-Associated Renal Toxicity in HIV-Infected Patients
Current HIV Research The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Current Drug Targets Herb-Drug Interactions: An Insight into Cardiovascular Diseases Based on Case Reports
Cardiovascular & Hematological Agents in Medicinal Chemistry Metabolism of Antiarrhythmics
Current Drug Metabolism Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Current Pharmaceutical Design 1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules
Mini-Reviews in Medicinal Chemistry Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents New Mucoadhesive Polymeric Film for Ophthalmic Administration of Acetazolamide
Recent Patents on Drug Delivery & Formulation Adoptive Immunotherapy for B-cell Malignancies Using CD19- Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety
Current Medicinal Chemistry Toll-Like Receptors and Inflammation in the CNS
Current Drug Targets - Inflammation & Allergy Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Comparison of the Mean Minimum Dose of Bolus Oxytocin for Proper Uterine Contraction during Cesarean Section
Current Clinical Pharmacology Pyrrolopyrazoles: Synthesis, Evaluation and Pharmacological Screening as Antidepressant Agents
Medicinal Chemistry Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Readjusting the Glucocorticoid Balance: An Opportunity for Modulators of 11β -Hydroxysteroid Dehydrogenase Type 1 Activity?
Endocrine, Metabolic & Immune Disorders - Drug Targets